Clinical Trial Update: The AOT (Acridine Orange and Taurolidine) Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Acridine Orange and Taurolidine (AOT) for infection/sepsis related to parenteral nutrition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Acridine Orange (Acridine Orange)
• Taurolidine (Taurolidine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Parenteral Nutrition, Infection | Phase 3 | Status: COMPLETED